16/03/2023at 13:38

William Demant Invest has nothing to say on scrapped GN capital raise

Despite being a major shareholder of the hearing company, the investment firm maintains it ”won’t comment on any potential future suggestions” GN makes to pay off its debts.

by marketwire & medwatch, translated by daniel pedersen

GN Group’s biggest shareholder, William Demant Invest, does not want to comment on the DKK 7bn (USD 1bn) capital raise that the Danish hearing company dropped on Tuesday, a day before its annual general meeting commenced.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

Access all locked articles
Receive our daily newsletters
Access our app

Get full access for you and your coworkers

Start a free company trial today

New GN chair wants to find debt solution – but can't say when
For subscribers
Shareholders' association to GN: ”Reach out to Willian Demant Invest"
For subscribers
GN retracts proposal to raise capital
For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

Antibiotic Dicillin has infected Danish and Icelandic patients Antibiotikummet Dicillin har smittet både danskere og islændinge med multiresistente bakterier, som patienterne sandsynligvis skal leve med resten af livet. | Foto: Lægemiddelstyrelsen / Pr

Pharma & biotech

Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market

Sandoz ends its collaboration with the secret CMO that made the contaminated antibiotic product and cannot rule out other drugs could be infected with multi-resistant bacteria.

For subscribers

Både danskere og islændinge har nu multiresistente bakterier i kroppen efter at have spist antibiotikummet Dicillin. | Foto: Lægemiddelstyrelsen / Pr

Other

Denmark: Violation of good manufacturing practice is source of contaminated antibiotic

For subscribers

Pharma & biotech

Analyst: New Novo Nordisk data sets the bar high for diabetes pills

For subscribers

Pharma & biotech

Zealand Pharma presents positive early-stage results for weight-loss candidate

For subscribers

Pharma & biotech

Genmab promotes senior VP for strategy to executive management

For subscribers

Medtech

Ambu wins European approval of two fifth-generation bronchoscopes

For subscribers

GN's scrapped capital raise: Norges Bank voted no, William Demant Invest abstained

While the Norwegian bank contributed substantially to GN’s decision to retract a proposed DKK 7bn capital raise, William Demant Invest did not stand in the way.

For subscribers

Hearing health

Shareholders' association to GN: ”Reach out to Willian Demant Invest"

The suggestion to enter dialog with the investment company, which some think is the best bid for buying GN, was met by cheers at the annual general meeting.

For subscribers

Medtech

Nordea finds new Ambu targets encouraging and trustworthy

Having looked over the Danish medtech company’s pipeline, the bank sees ”an opportunity for a strong double-digit earnings growth in the medium to long term.”

William Demant Invest has nothing to say on scrapped GN capital raise

Read the whole article

With your free trial you get:

Get full access for you and your coworkers

Related articles:

New GN chair wants to find debt solution – but can't say when

Shareholders' association to GN: ”Reach out to Willian Demant Invest"

GN retracts proposal to raise capital

Sign up for our newsletter

Front page now

Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market

Denmark: Violation of good manufacturing practice is source of contaminated antibiotic

Analyst: New Novo Nordisk data sets the bar high for diabetes pills

Zealand Pharma presents positive early-stage results for weight-loss candidate

Genmab promotes senior VP for strategy to executive management

Ambu wins European approval of two fifth-generation bronchoscopes

Further reading

GN's scrapped capital raise: Norges Bank voted no, William Demant Invest abstained

Shareholders' association to GN: ”Reach out to Willian Demant Invest"

Nordea finds new Ambu targets encouraging and trustworthy

Jobs